DLA Piper advises Alimera Sciences in acquisition by ANI Pharmaceuticals
DLA Piper advised Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions, in its acquisition by ANI Pharmaceuticals, a diversified biopharmaceutica…